Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
Recruiting in Palo Alto (17 mi)
+174 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Mannkind Corporation
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data
Trial Summary
What is the purpose of this trial?
Pulmonary Safety in Diabetics with T/I
Research Team
Eligibility Criteria
Inclusion Criteria
Nonsmoking
Body mass index <42 kg/m2
FEV1 greater than or equal to 70% of predicted , DLco and TLC greater than or equal to 80% of predicted at screening
See 5 more
Treatment Details
Interventions
- Technosphere® Insulin Inhalation Powder (Insulin)
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Usual careExperimental Treatment1 Intervention
Usual care
Group II: TI Inhalation PowderExperimental Treatment1 Intervention
Technosphere® Insulin Inhalation Powder
Group III: Non-diabetesActive Control1 Intervention
Subjects without abnormalities in glucose control (Note: Hypoglycemia and HbA1c were not reported for this group)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Diabetes Care CenterSalinas, CA
Cedar-Crosse Research CenterChicago, IL
University of Texas Southwestern Medical CenterDallas, TX
Clinical Research Department Wenatchee Valley Medical CenterWenatchee, WA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Mannkind Corporation
Lead Sponsor
Trials
61
Patients Recruited
8,400+